2026 evidence-based hair restoration guide
PRP vs Exosomes for Hair Loss: Which Delivers the Stronger Case in 2026?
If you want the hair-loss procedure backed by the stronger clinical evidence,
PRP leads in 2026. Exosome-based scalp treatments are promising—but promising
is not the same as proven. Compare the evidence, outcomes, cost, safety and
candidacy before putting money behind either treatment.
PRP or exosomes? Here’s the decision that matters
If your priority is stronger clinical evidence for androgenetic alopecia,
PRP is the more defensible starting point in 2026.
PRP hair restoration
uses a concentrated portion of your own blood and has been evaluated in
multiple randomized trials and systematic reviews.
ASCEplus HRLV
takes a different route. It is a professionally manufactured
extracellular-vesicle scalp formulation with supporting ingredients.
It requires no blood draw and may fit patients looking for another
non-surgical option.
But here is the key distinction:
PRP has the stronger evidence base. ASCEplus HRLV has the newer story.
That does not make PRP automatically better for everyone. Neither treatment
creates new follicles. Neither guarantees regrowth. And neither deserves
your money until someone determines why your hair is thinning,
whether viable follicles remain, and what outcome can realistically be measured.
Side-by-side comparison
PRP vs exosomes for hair loss at a glance
| Feature | PRP hair treatment | ASCEplus HRLV |
|---|---|---|
| Source | Your own blood. |
A professionally manufactured extracellular-vesicle scalp formulation. Exact source and version should be confirmed from the current label. |
| What you are getting |
Concentrated platelets in plasma. The exact cellular and platelet profile depends on the system, patient and protocol. |
Extracellular vesicles with supporting scalp-care ingredients. Some current labels list Rosa damascena callus-derived extracellular vesicles. |
| Living stem cells | No. | No. It is not a stem-cell transplant or living-cell therapy. |
| Blood draw | Yes. | No. |
| Delivery | PRP is injected into selected thinning areas after the blood is processed. |
Professionally applied using the delivery protocol selected for the patient and product. |
| Evidence in 2026 |
More established. Multiple randomized trials, systematic reviews and meta-analyses report potential improvements in hair density. |
Still emerging. Early human evidence is encouraging, but controlled product-specific evidence remains limited. |
| Best reason to consider it |
You want an autologous procedure with the stronger current clinical evidence base. |
You want a professionally manufactured, blood-free scalp option within a broader non-surgical hair-restoration plan. |
| Biggest limitation |
Results depend heavily on diagnosis, follicle viability, blood values, preparation method and treatment consistency. |
“Exosome treatment” covers very different products. Evidence for one formulation cannot automatically be applied to another. |
| Creates new follicles? | No. | No. |
The takeaway: do not pay for a buzzword. Pay for a treatment
strategy built around measurable follicle activity.
Autologous treatment
What is PRP for hair loss—and why does it keep getting attention?
PRP stands for platelet-rich plasma. A small amount of blood is drawn,
processed in a centrifuge and separated so the platelet-rich portion can
be concentrated. That preparation is then injected into targeted scalp
areas where thinning exists and viable follicles remain.
Platelets release signalling proteins and growth factors involved in tissue
response. In hair restoration, PRP is used to support the scalp environment
and existing follicles.
For the right patient, that may translate into outcomes such as
improved visible density, reduced shedding and support for
miniaturizing follicles that are still active.
More evidence. Your own blood. Measurable goals.
- Autologous: prepared from your own blood.
-
Better studied: it has the stronger evidence base
of the two treatments compared here. -
Customizable: different systems can produce different
platelet concentrations and cellular profiles. -
Low downtime: many suitable patients return to
normal routines quickly.
PRP is not magic—and not all PRP is identical
- A blood draw is required.
- Multiple scalp injections are required.
- A treatment series and maintenance may be needed.
- Results vary between patients and protocols.
-
Blood values, platelet health, diagnosis and follicle viability can
influence response.
The real objective is not to sell you PRP.
It is to determine whether your hair is still in a stage where PRP has
viable follicles to work with.
LMC offers several PRP and PRF preparation systems rather than forcing
every patient into one generic protocol. Compare the
four-tier PRP and PRF hair-restoration system
or read the guide to
PRP vs PRF for hair loss
.
Manufactured scalp formulation
What is ASCEplus HRLV exosome hair treatment?
Exosomes are a subtype of extracellular vesicle involved in cell-to-cell
signalling. Sounds impressive—but the word alone should not convince you
to book a treatment.
“Exosome treatment” can describe products with very different sources,
contents, concentrations, manufacturing methods, storage requirements and
delivery protocols.
At LMC, the exosome-based hair option is ASCEplus HRLV,
also written ASCE+ HRLV, developed by ExoCoBio for professional scalp care.
Current global product materials describe a plant-derived extracellular-vesicle
complex, while a current U.S. label lists Rosa damascena
callus extracellular vesicles and biotin.
[6]
Product versions and market-specific materials can differ, so the current
LMC vial, carton and instructions for use should be checked before making
source-specific claims.
One point needs to be crystal clear:
ASCEplus HRLV is a cell-free formulation. It is not a living stem-cell
transplant.
Why the exact exosome product matters—a lot
This is where weak comparisons fall apart.
A study involving adipose-derived extracellular vesicles does not automatically
prove that placental, umbilical-cord-derived or plant-derived products will
produce the same result.
The source matters. The dose matters. The manufacturing process matters.
The delivery method matters.
“Contains exosomes” is not an outcome.
What matters is the exact product being used, how it is being delivered and
what evidence actually applies to that formulation.
Learn more about
ASCEplus HRLV treatment, candidacy and current pricing at LMC
.
Evidence check
What does the research actually show in 2026?
The stronger evidence case
A 2024 systematic review included eight randomized controlled trials
and one prospective cohort involving 291 male participants.
Six studies reported a statistically significant increase in hair density.
Five reported a statistically significant increase in hair count.
[1]
That is meaningful—but not flawless evidence. Researchers still identified
study-quality limitations, risk of bias and major differences between
PRP protocols.
A separate 2024 systematic review and meta-analysis also concluded that
PRP can increase hair density in androgenetic alopecia while warning
about heterogeneity and possible publication bias.
[2]
Among these two procedures, PRP currently gives patients the stronger
research foundation.
Exciting—but earlier
A 2025 systematic review examined 11 clinical studies across different
extracellular-vesicle sources, formulations, alopecia types and delivery
methods.
Every included study reported improvement in at least one hair-related
measurement.
[3]
Encouraging? Absolutely.
Case closed? Not even close.
The evidence remains highly heterogeneous and includes relatively few
controlled trials.
A June 2026 review reached a similarly cautious conclusion. Early clinical
signals exist, but small samples, inconsistent outcomes, manufacturing
variability, limited controls and weak long-term data remain major issues.
[7]
The science deserves attention. The marketing sometimes outruns it.
What evidence exists for ASCEplus HRLV specifically?
A 2024 report described one 54-year-old man with androgenetic alopecia who
received ASCEplus HRLV-S, a rose-derived version, with
non-invasive electroporation every three weeks for 12 sessions.
The authors reported improvements in hair measurements without serious
adverse events.
[4]
Interesting? Yes.
Enough to prove superiority? No.
It involved one patient. There was no control group. Electroporation was
part of the intervention. One author was affiliated with ExoCoBio.
The report cannot establish an average response, separate the formulation
from the delivery method, validate every HRLV version or prove superiority
to PRP.
The 2026 verdict: PRP wins on evidence maturity.
Extracellular-vesicle treatments win on novelty and emerging scientific
interest. Those are not the same thing.
No robust randomized head-to-head trial has established ASCEplus HRLV or
HRLV-S as superior to PRP. Strong evidence showing that combining both
automatically produces better outcomes is also lacking.
For a deeper review of PRP studies, read LMC’s guide to
whether PRP works for hair loss based on 2026 evidence
.
Treatment selection
So which hair-loss treatment should you choose?
Do not start with the treatment.
Start with the diagnosis.
Androgenetic alopecia is not the same problem as iron-deficiency shedding.
Neither is the same as thyroid-related hair loss, telogen effluvium,
alopecia areata, traction alopecia, medication-related shedding,
inflammatory disease or scarring alopecia.
Throwing an expensive treatment at the wrong diagnosis is still the wrong
treatment.
- You have early to moderate pattern thinning.
- Viable follicles remain.
- You want the stronger current evidence base.
- You are comfortable with a blood draw and scalp injections.
- Your medical and platelet health support treatment.
- You have early or moderate thinning or shedding.
- You want a professionally manufactured scalp formulation.
- You prefer avoiding a blood draw.
- Your assessment supports using HRLV alone or within a broader plan.
- You understand that product-specific evidence remains preliminary.
- Hair loss appeared suddenly.
- Hair loss is patchy.
- Your scalp is painful, inflamed or scarred.
-
Thyroid, iron, hormonal, nutritional, autoimmune or medication-related
hair loss may be involved. - The area is smooth, shiny or completely bald.
If the follicle is gone, spending more on PRP or exosomes will not
bring it back.
That is why early assessment matters. Non-surgical treatments generally
depend on follicles that are still viable.
Combination planning
Can you combine PRP and ASCEplus HRLV?
Yes—but more treatment does not automatically mean more hair.
PRP and ASCEplus HRLV may be incorporated into the same personalized
hair-restoration plan when clinically appropriate. They may be staged as
separate sessions or used within a broader non-surgical strategy.
The reason for combining them should be clear.
Not because combining treatments sounds more advanced.
Not because a bigger package costs more.
The provider should be able to explain
what each treatment is expected to contribute and exactly how
the response will be measured.
As of August 2026, strong product-specific evidence proving that PRP plus
ASCEplus HRLV consistently outperforms PRP alone is lacking.
Ask one simple question before paying for both:
What measurable result are we trying to improve by adding the second treatment?
That question can save you money.
LMC may also consider
PRF hair restoration
,
scalp mesotherapy
or
MCT-enhanced autologous plasma
based on the assessment.
Practical expectations
Sessions, results timeline and cost: what are you actually paying for?
Plan for a series—not a miracle session
Many PRP programs begin with roughly three to five sessions spaced
several weeks apart.
ASCEplus HRLV is also commonly performed as a series.
Maintenance may be recommended for either option.
The right number depends on what your scalp is actually doing.
Think in months, not weekends
Hair follicles move through slow growth cycles.
Reduced shedding may appear before visible changes in density.
Changes in calibre and density usually need several months before they
can be assessed responsibly.
Standardized photography and objective scalp measurements matter more
than bathroom-mirror photos taken under different lighting.
If you are spending thousands on treatment, you should know whether
it is actually changing anything.
PRP starts at $500. HRLV starts at $700.
As of August 12, 2026, RegenLab PRP starts at
$500 for one session or $1,200 for three.
ASCEplus HRLV is listed at
$700 for one session or $3,500 for six.
Advanced PRP and PRF tiers cost more.
But comparing treatments by session price alone is a mistake.
A cheaper treatment that does nothing for your diagnosis is not cheap.
A larger package you do not need is not better value.
The better investment is the treatment that fits the problem—and gets measured.
Prices are before applicable tax, may change and may be subject to eligibility
or promotional terms. Confirm the
current LMC treatment prices
.
Eligible purchases may qualify for
treatment financing
.
Safety and regulation
What are the risks—and what should you ask before treatment?
PRP risks and suitability
Temporary scalp tenderness, redness, swelling, pinpoint bleeding,
bruising or headache may occur after PRP.
Less common risks include infection, bleeding, scarring, nerve or
blood-vessel injury and an unsatisfactory response.
PRP may not be suitable for some people with active scalp infection,
blood or platelet disorders, severe thrombocytopenia, uncontrolled
illness, significant immunosuppression or current chemotherapy.
Medications and supplements must be reviewed. Do not stop prescribed
anticoagulants, antiplatelet medication or anti-inflammatory medication
unless the prescribing clinician tells you to do so.
Health Canada states that same-patient PRP prepared and administered
in one procedure by an authorized practitioner falls within provincially
or territorially regulated medical or dental practice. It also states
that Health Canada has not reviewed PRP’s safety, efficacy or quality
for therapeutic uses.
[8]
ASCEplus HRLV risks and suitability
Possible temporary reactions include redness, sensitivity, swelling,
itching, tenderness, pinpoint scabbing or bruising depending on the
delivery method.
Allergy or sensitivity to formulation ingredients and infection related
to scalp procedures must also be considered.
Tell the provider about scalp conditions, allergies, pregnancy or
breastfeeding, immune conditions, medications, recent procedures and
previous hair-loss diagnoses.
The regulatory picture matters:
“exosome” is a scientific term—not a stamp of approval.
Health Canada’s April 2026 final notice states that exosome and
extracellular-vesicle products are classified individually based on their
source, composition, claims, level of action and intended use.
[5]
Do not ask only, “Is this an exosome treatment?”
Ask:
What exact product is it? What is in it? How is it classified?
How is it delivered? What evidence applies to this exact formulation?
Measure before treating
How LMC decides what your hair actually needs
LMC does not start with, “Which package do you want?”
It starts with a more useful question:
What is happening to your follicles?
-
Find the pattern.
Your provider reviews when the hair loss started, where it is happening,
how quickly it is changing, family history, shedding, medical history,
medication use, stress, hormonal factors, nutrition and previous treatment. -
Measure what is still there.
HairMetrix AI hair and scalp analysis
can measure density, follicular units, shaft calibre and
terminal-to-vellus ratio. It does not replace medical diagnosis, but it
gives the treatment plan something far more useful than guesswork:
a baseline. -
Investigate red flags.
Sudden, patchy, inflammatory, scarring or medically suspicious hair loss
may require assessment by a physician or dermatologist and possible
laboratory testing.
TrichoTest genetic analysis
may provide additional treatment-response information in selected cases. -
Choose the simplest plan that makes sense.
More expensive is not automatically more effective. More treatments are
not automatically better. The provider should be able to explain why PRP,
ASCEplus HRLV, PRF, another option or medical referral fits the findings. -
Prove whether it is working.
Take standardized photographs. Repeat objective measurements.
Track density. Track calibre. Track miniaturization. Then reassess.
If the numbers are not moving, the plan should not continue forever
simply because you already started it.
That is what outcome-focused hair restoration should look like.
Explore LMC’s full range of
non-surgical hair-restoration options in Richmond Hill
.
Straight answers
PRP vs exosomes for hair loss: frequently asked questions
Is PRP better than exosomes for hair loss?
For patients who prioritize the stronger current evidence base,
PRP has the advantage in 2026. That does not mean PRP is best for
every patient. It means PRP has been studied more extensively for
androgenetic alopecia than commercial extracellular-vesicle scalp
treatments. The right choice still depends on diagnosis, follicle
viability, medical history and treatment goals.
What is the biggest difference between PRP and ASCEplus HRLV?
PRP comes from your own blood. ASCEplus HRLV is a professionally
manufactured extracellular-vesicle scalp formulation. PRP requires
a blood draw and scalp injections. HRLV does not require a blood
draw and follows a product-specific professional application protocol.
Are ASCEplus HRLV exosomes stem cells?
No. ASCEplus HRLV is a cell-free formulation. It is not a living
stem-cell transplant. Exact formulation should be confirmed from
the current product packaging and instructions.
Can PRP and ASCEplus HRLV be used together?
Yes, when clinically appropriate. But there is not yet strong
product-specific evidence proving that combining them consistently
produces better outcomes than PRP alone. A combination plan should
have a defined goal and a way to measure whether the added treatment
is earning its place.
How many sessions do you need?
Many PRP plans begin with about three to five sessions. ASCEplus HRLV
is also commonly performed as a series. The correct number depends on
your diagnosis, thinning stage, follicle activity, scalp condition,
protocol and response.
How fast will you see hair-restoration results?
Think months, not days. Changes in shedding may appear first.
Visible density and thickness take longer. Standardized photographs
and scalp measurements provide a much better comparison than casual
phone photos.
Can PRP or exosomes regrow hair on a completely bald area?
Usually not if permanent follicle loss has already occurred.
Neither treatment creates brand-new follicles. Long-standing smooth
or shiny bald areas may require a hair-transplant assessment instead.
How much do PRP and ASCEplus HRLV cost at LMC?
As of August 12, 2026, RegenLab PRP starts at $500 for one session
or $1,200 for three. ASCEplus HRLV is listed at $700 for one session
or $3,500 for six. Advanced PRP and PRF options cost more. Prices,
promotions, taxes and recommendations may change.
Is exosome hair treatment approved by Health Canada?
Do not assume regulatory authorization simply because a treatment is
marketed as an “exosome” product. Health Canada classifies these
products individually based on source, composition, claims, intended
use and other characteristics. Ask exactly what product is being used
and what regulatory status applies to it.
Complimentary hair consultation
Stop guessing. Find out what your hair can still respond to.
You can spend months comparing PRP, exosomes, PRF, serums, supplements and
miracle claims.
Or you can start with the information that actually matters:
How much viable hair do you still have?
What type of hair loss are you dealing with?
Which treatment has a defensible reason to work for your pattern?
LMC – Laser Medical Clinic combines clinical history, scalp assessment and
HairMetrix AI measurements to help determine whether PRP, ASCEplus HRLV,
another treatment or medical referral makes sense.
The goal is not to sell you the longest treatment list.
The goal is to protect the follicles you still have and put your money
behind a plan that can be measured.
Visit:
10168 Yonge Street, Unit 203, Richmond Hill, Ontario L4C 1T6
Call or text:
647-560-8333
Serving Richmond Hill, Toronto, Vaughan, Markham, Aurora, Newmarket,
King City, York Region and the GTA.
References and evidence sources
-
Donnelly C, et al. The role of platelet-rich plasma in androgenetic
alopecia: a systematic review.
Journal of Cosmetic Dermatology. 2024;23(5):1551-1559.
PubMed
.
doi:10.1111/jocd.16185. -
Kieling L, Konzen AT, Zanella RK, Valente DS.
Is autologous platelet-rich plasma capable of increasing hair density
in patients with androgenic alopecia? A systematic review and meta-analysis
of randomized clinical trials.
Anais Brasileiros de Dermatologia. 2024;99(6):847-862.
PubMed
.
doi:10.1016/j.abd.2024.01.002. -
Al Ameer MA, et al. Exosomes and hair regeneration: a systematic review
of clinical evidence across alopecia types and exosome sources.
Clinical, Cosmetic and Investigational Dermatology.
2025;18:2215-2227.
PubMed
.
doi:10.2147/CCID.S543451. -
Lueangarun S, Cho BS, Tempark T, et al.
Rose stem cell-derived exosomes for hair regeneration enhancement via
noninvasive electroporation in androgenetic alopecia.
Journal of Cosmetic Dermatology. 2024;23(11):3791-3794.
PubMed
.
doi:10.1111/jocd.16463. -
Health Canada. Final notice: Classification of topical products containing
human-derived exosomes, human extracellular vesicles, or human
cell-conditioned media. Published April 10, 2026.
Read the official notice
. -
U.S. National Library of Medicine DailyMed.
EXOSCRT Scalp Care HRLV label. The label lists biotin and
Rosa damascena callus extracellular vesicles and identifies
the U.S. listing as an unapproved drug product.
View the label
.
Product labels and regulatory status may differ by market and version. -
Malih S, et al. Exosome-driven treatments for hair regrowth in androgenetic
alopecia: a systematic review of preclinical studies, clinical experiments,
safety, and future prospects.
Molecular Biology Reports. 2026;53:1046.
View the review
.
doi:10.1007/s11033-026-12255-2. -
Health Canada. Health Canada clarifies position on Platelet Rich Plasma
treatments. Published July 26, 2019.
Read the official notice
.
Medical disclaimer:
This article is educational and does not diagnose hair loss or replace
individualized medical advice, informed consent or assessment by a qualified
healthcare professional. Treatment suitability, benefits, risks,
alternatives and expected outcomes must be reviewed individually.
Results vary, and no hair-restoration treatment can guarantee regrowth.
To book your complimentary consultation appointment, call us at 416-548-6548
Book a Consultation